Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Is solifenacin succinate a safe and effective treatment for overactive bladder syndrome?

Nature Clinical Practice Urology volume 2, pages 82–83 (2005)Cite this article

boxed-textCardozo L et al. (2004) Randomized, double-blind placebo controlled trial of the once daily antimuscarinic agent solifenacin succinate in patients with overactive bladder. J Urol 172: 1919–1924

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Acknowledgements

The synopsis was written by Suzanne Farley, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Department of Urology at Vanderbilt University, Nashville, TN

    Roger Dmochowski

  2. Uniformed Services University of the Health Sciences, Bethesda, MD

    Roger Dmochowski

Authors
  1. Roger Dmochowski
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Roger Dmochowski.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dmochowski, R. Is solifenacin succinate a safe and effective treatment for overactive bladder syndrome?. Nat Rev Urol 2, 82–83 (2005). https://doi.org/10.1038/ncpuro0092

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro0092

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing